Mcia Inc Gilead Sciences, Inc. Transaction History

Mcia Inc

$447 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$73.27 - $83.09 $84,993 - $96,384	-1,160 Reduced 7.74%	13,824 $1.12 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $953,899 - $1.04 Million	-12,901 Reduced 46.27%	14,984 $1.12 Million
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $636,887 - $726,459	-8,379 Reduced 23.11%	27,885 $2.15 Million
Q1 2023 Apr 14, 2023	BUY	$77.31 - $88.08 $325,243 - $370,552	4,207 Added 13.12%	36,264 $3.01 Million
Q4 2022 Jan 10, 2023	BUY	$62.32 - $89.47 $148,633 - $213,385	2,385 Added 8.04%	32,057 $0
Q3 2022 Oct 20, 2022	BUY	$59.54 - $68.01 $93,299 - $106,571	1,567 Added 5.58%	29,672 $1.96 Million
Q2 2022 Jul 08, 2022	BUY	$57.72 - $65.01 $228,109 - $256,919	3,952 Added 16.36%	28,105 $1.76 Million
Q1 2022 Apr 12, 2022	SELL	$57.92 - $72.58 $109,179 - $136,813	-1,885 Reduced 7.24%	24,153 $1.5 Million
Q4 2021 Jan 12, 2022	BUY	$64.88 - $73.64 $493,412 - $560,032	7,605 Added 41.26%	26,038 $1.88 Million
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $75,271 - $81,209	1,112 Added 6.42%	18,433 $1.25 Million
Q2 2021 Jul 09, 2021	BUY	$63.47 - $69.35 $2,031 - $2,219	32 Added 0.19%	17,321 $1.17 Million
Q1 2021 Apr 14, 2021	BUY	$60.0 - $68.46 $218,280 - $249,057	3,638 Added 26.65%	17,289 $1.12 Million
Q4 2020 Jan 13, 2021	BUY	$56.65 - $64.55 $773,329 - $881,172	13,651 New	13,651 $853,000
Q4 2020 Jan 12, 2021	SELL	$56.65 - $64.55 $1.01 Million - $1.15 Million	-17,793 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$62.1 - $78.08 $1.1 Million - $1.39 Million	17,793 New	17,793 $1.15 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $54,998 - $64,560	-773 Closed	0 $0
Q3 2017 Nov 01, 2017	SELL	$72.11 - $85.47 $246,976 - $292,734	-3,425 Reduced 81.59%	773 $63,000
Q2 2017 Aug 16, 2017	BUY	N/A	4,198	4,198 $297,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcia Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcia Inc with notifications on news.

Account